191725-82-3

Basic information

• Product Name: Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI)
• Synonyms: Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI);3-Acetyl-4-Methoxy pyridine;1-(4-Methoxypyridin-3-yl)ethanone;1-(4-Methoxy-3-pyridinyl)ethanone;1-(4-Methoxy-3-pyridyl)ethanone;1-(4-methoxypyridin-3-yl)ethan-1-one;Ethanone, 1-(4-methoxy-3-pyridinyl)-
• CAS NO: 191725-82-3
• Molecular Formula: C8H9NO2
• Molecular Weight: 151.16256
• Product Categories: ACETYLGROUP
• Mol File: 191725-82-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 264.2±20.0 °C(Predicted)
• Appearance: /
• Density: 1.093±0.06 g/cm3(Predicted)
• PKA: 4.75±0.18(Predicted)
• CAS DataBase Reference: Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI)(191725-82-3)
• EPA Substance Registry System: Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI)(191725-82-3)

Safety Data

• Hazardous Substances Data: 191725-82-3(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI) is a chemical compound with the molecular formula C8H9NO2. It is also known by its common name, 4-Methoxy-3-pyridinyl methyl ketone. Ethanone, 1-(4-methoxy-3-pyridinyl)- (9CI) is a yellow oil with a molecular weight of 151.16 g/mol. It is used in the pharmaceutical industry as a building block in the synthesis of various drugs and pharmaceutical products. Its main applications include the production of medications for the treatment of diseases such as cancer, infections, and neurological disorders. Additionally, it is used as a reagent and intermediate in organic synthesis.

Upstream product

• 116922-69-1 rac-4-chloro-3-(1-hydroxyethyl)pyridine 
• 1807467-70-4 1-(4-chloropyridin-3-yl)ethanone hydrochloride 
• 124-41-4 sodium methylate 
• 116922-73-7 1-(4-chloropyridin-3-yl)ethanone 

Relevant articles and documents

FUNCTIONALIZED HETROARYL ENONES EXHIBITING NRF2 ACTIVATION AND THEIR METHOD OF USE

Pharmaceutical compositions are disclosed, which include functionalized hetroaryl enones and are useful for treating or preventing a disease, disorder or condition associated with an NRF2-regulated pathway and/or which involves oxidative stress.

Piperidine and tetrahydropyridine derivatives

A class of substituted piperidine and tetrahydropyridine derivatives, linked through the 4-position thereof via an alkylene chain to a fused bicyclic heteroaromatic moiety such as indolyl, and further substituted at the 1-position by an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl-alkyl, aryl-alkyl or heteroaryl-alkyl moiety, are selective agonists of 5-HT1 -like receptors, being potent agonists of the human 5-HT1Dα; receptor subtype whilst processing at least a 10-fold selective affinity for the 5-HT1Dα; receptor subtype relative to the 5-HT1Dβ; subtype; they are therefore useful in the treatment and/or prevention of clinical conditions, in particular migraine and associated disorders, for which a subtype-selective agonist of 5-HT1D receptors is indicated, whilst eliciting fewer side-effects, notably adverse cardiovascular events, than those associated with non-subtype-selective 5-HT1D receptor agonists.